| Functional morphology of the blood-brain barrier in health and disease |
81 |
| Current state of Alzheimer's fluid biomarkers |
76 |
| Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers |
70 |
| The role of brain barriers in fluid movement in the CNS: is there a 'glymphatic' system? |
60 |
| Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease |
52 |
| Novel, improved grading system(s) for IDH-mutant astrocytic gliomas |
50 |
| Tau filaments from multiple cases of sporadic and inherited Alzheimer's disease adopt a common fold |
42 |
| Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas |
40 |
| Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways |
40 |
| Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo |
39 |
| Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease |
37 |
| Post-stroke inflammation-target or tool for therapy? |
37 |
| Inflammation in ALS/FTD pathogenesis |
36 |
| Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis |
34 |
| Galectin- a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease |
32 |
| Energy metabolism in ALS: an underappreciated opportunity? |
31 |
| Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes |
31 |
| Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology |
31 |
| Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? |
31 |
| Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience |
31 |
| Aging alters the immunological response to ischemic stroke |
30 |
| Questions concerning the role of amyloid-beta in the definition, aetiology and diagnosis of Alzheimer's disease |
30 |
| The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis |
29 |
| Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats |
27 |
| Rapid lymphatic efflux limits cerebrospinal fluid flow to the brain |
27 |
| Does Parkinson's disease start in the gut? |
27 |
| The complexity of neuroinflammation consequent to traumatic brain injury: from research evidence to potential treatments |
26 |
| Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations |
25 |
| Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART |
25 |
| Mechanical disruption of the blood-brain barrier following experimental concussion |
25 |
| Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features |
24 |
| Dissecting the genetic basis of focal cortical dysplasia: a large cohort study |
24 |
| FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy |
24 |
| Spread of aggregates after olfactory bulb injection of alpha-synuclein fibrils is associated with early neuronal loss and is reduced long term |
24 |
| Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations |
24 |
| A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity |
24 |
| The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis? |
24 |
| Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis |
24 |
| MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways |
24 |
| Targeting pericytes for therapeutic approaches to neurological disorders |
24 |
| Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma |
23 |
| Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau |
23 |
| The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS |
23 |
| LRRK2 modifies alpha-syn pathology and spread in mouse models and human neurons |
23 |
| Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure |
22 |
| Differential alpha-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity |
22 |
| Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence |
22 |
| Microglial cell loss after ischemic stroke favors brain neutrophil accumulation |
22 |
| Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson's models |
21 |
| Depopulation of dense alpha-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model |
21 |
